COVID Long-Haul
9
5
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Long COVID-19 [11C]CPPC Study
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
Mind Body Intervention for Long COVID-19
Long-Covid-19 Alleviation Through Learning Mindfulness Study
Comprehensive Imaging Exam of Convalesced COVID-19 Patients
Covid-19 Long Immunité IMagerie (CLIIM)
Cardiopulmonary Exercise Tests in Patients With Long COVID
Neural and Cognitive Consequences of COVID-19 Survival
Open-label, Post-marketing, Prospective Study to Assess Impact of COVID-19 on Cognitive Function in Patients